A. Ramírez-Jiménez et al. / Journal of Organometallic Chemistry 694 (2009) 2965–2975
2973
5.8. Complex 1h
7.09 (6H, m, H-m, H-p), 7.18 (1H, d, J = 1.7 Hz, H-14), 7.19 (1H, d,
J = 8.4 Hz, H-11), 7.24 (1H, dd, J = 8.4, 1.7 Hz, H-12), 7.42 (1H, d,
J = 7.6 Hz, H-5), 7.53 (1H, ddd, J = 7.6, 5.4, 1.4 Hz, H-3), 7.58–7.63
(5H, m, H-17, H-o), 7.83 (1H, ddd, J = 7.6, 7.6, 1.7 Hz, H-4), 7.86
(1H, ddd, J = 7.7, 7.7, 1.7 Hz, H-18), 8.29 (1H, d, J = 7.7 Hz, H-19),
8.39 (1H, s, H-7), 9.84 (1H, d, J = 4.7 Hz, H-16), 10.27 (1H, d,
J = 5.4 Hz, H-2); 13C NMR (75 MHz, CDCl3), d: 20.8 (Ar-CH3), 116.4
(C-14), 120.7 (C-11), 125.2 (C-13), 125.4 (C-19), 126.1 (C-3),
126.6 (C-5), 127.0 (C-17), 128.0 (C-m, C-p), 130.2 (C-9), 134.4 (C-
p), 135.0 (C-12), 139.0 (C-4), 139.9 (C-18), 141.9 (C-7), 147.6 (C-
ipso), 148.2 (C-16), 149.1 (C-20), 151.4 (C-2), 151.9 (C-6), 162.6
(C-10), 166.0 (C-21), 119Sn NMR (112 MHz, CDCl3) d: ꢀ582.7; MS
(FAB+) [m/z] (%): [MÅ+, 607], (2), [(MꢀPh)+, 530] (1), [(MꢀPyCOO)+,
485] (15), [(MꢀPyCOOꢀ2Ph)+, 331] (3); HR-MS (FAB+) m/z:
485.0676; (Calcd. for the fragment ion C25H21ON2Sn), Observed
485.0686. Anal. Calc. for C31H25N3O3Sn: C, 61.42; H, 4.16; N, 6.93.
Found: C, 61.23; H, 4.23; N, 6.88%.
Following the procedure described for complex 1g, complex 1h
was prepared from 0.1 mL (1.048 mmol) of 2-pyridinecarboxalde-
hyde, 0.1615 g (1.048 mmol) of 2-amino-4-nitrophenol, 0.2609 g
(1.048 mmol) of dibutyltin oxide, and 0.1290 g (1.048 mmol) of
2-picolinic acid thereby giving 0.5247 g (83.7% yield) of a brown-
orange solid, m.p. = 211–216 °C; IR (KBr cmꢀ1): 1648 (s, masym
CO2), 1354 (s, msymCO2), 1593 (s, mC@N), 416 (w, m
Sn–N); 1H NMR
(300 MHz, CDCl3) d: 0.50 (6H, t, J = 7.3 Hz, Sn-(CH2)3CH3), 0.77–
1.17 (12H, m, Sn-(CH2)3CH3), 7.01 (1H, d, J = 9.4 Hz, H-11), 7.68
(1H, ddd, J = 7.6, 5.3, 1.1 Hz, H-3), 7.75 (1H, ddd, J = 7.6, 5.4,
1.2 Hz, H-17), 7.91 (1H, d, J = 7.6 Hz, H-5), 8.12 (1H, ddd, J = 7.6,
7.6, 1.7 Hz, H-4), 8.14 (1H, ddd, J = 7.7, 7.6, 1.7 Hz, H-18), 8.22
(1H, dd, J = 9.4, 2.5 Hz, H-12), 8.55 (1H, d, J = 7.7 Hz, H-19), 8.65
(1H, d, J = 2.5 Hz, H-14), 9.00 (1H, s, H-7), 9.65 (1H, d, J = 4.5 Hz,
H-16), 9.87 (1H, d, J = 5.0 Hz, H-2); 13C NMR (75 MHz, CDCl3), d:
13.4 (Cd), 26.2 (C ), 27.8 (Cb), 32.9 (C ), 113.8 (C-11), 121.3
c
a
(C-12), 125.9 (C-19), 126.7 (C-5), 127.3 (C-3), 127.5 (C-17), 128.4
(C-14), 129.7 (C-9), 135.8 (C-13), 139.6 (C-4), 139.6 (C-18), 146.2
(C-7), 147.7 (C-6), 147.9 (C-16), 149.9 (C-20), 151.7 (C-2), 166.7
(C-10), 170.4 (C-21), 119Sn NMR (112 MHz, CDCl3) d: ꢀ441.1; MS
(FAB+) [m/z] (%): [MÅ+, 598] (2); [(MꢀPyCOO)+, 476] (100),
[(MꢀPyCOOꢀ2Bu)+, 362] (35), [(MꢀPyCOOꢀNO2)+, 430] (10);
HR-MS (FAB+) m/z: 476.0996 (Calcd. for the fragment ion
C20H26N3O3Sn), Observed 476.0996. Anal. Calc. for C26H30N4O5Sn:
C, 52.29; H, 5.06; N, 9.38. Found: C, 51.78; H, 5.11; N, 9.10%.
5.11. Complex 1k
Following the procedure described for 1i, complex 1k was
formed from 0.1 mL of 2-pyridinecarboxaldehyde, 0.1509 g
(1.051 mmol) of 2-amino-4-chlorophenol, 0.3031 g diphenyltin
oxide and 0.1291 g (1.048 mmol) 2-picolinic acid, which was re-
fluxed for 20 min and which lead to 0.5445 g (83% yield) of a red
solid, m.p. 280–285 °C; IR (KBr cmꢀ1): 1659 (s,
(s, symCO2), 1594 (s, C@N), 419 (w,
m
asymCO2), 1359
m
m
m
Sn–N); 1H NMR (300 MHz,
CDCl3) d: 6.91–7.11 (6H, m, H-m, H-p), 7.23 (1H, d, J = 9.4 Hz, H-
11), 7.35 (1H, dd, J = 9.4, 2.5 Hz, H-12), 7.36 (1H, s, H-14), 7.50
(1H, d, J = 7.6 Hz, H-5), 7.54–7.52 (5H, m, H-3, H-o), 7.67 (1H,
ddd, J = 7.5, 5.2, 1.1, H-17), 7.89 (2H, ddd, J = 7.7, 7.5, 1.1 Hz, H-4,
H-18), 8.33 (1H, d, J = 7.7 Hz, H-19), 8.38 (s, 1H, H-7), 9.82 (1H, d,
J = 5.2 Hz, H-16), 10.29 (1H, d, J = 5.2 Hz, H-2); 13C NMR (75 MHz,
CD2Cl2), d: 116.7 (C-14), 120.6 (C-13), 122.4 (C-11), 125.6 (C-19),
127.1 (C-3), 127.3 (C-17), 128.2 (C-5), 128.4 (C-m, p), 131.3 (C-9),
133.5 (C-12), 134.3 (C-o), 139.8 (C-4), 140.5 (C-18), 144.5 (C-7),
147.3 (C-ipso), 148.3 (C-16), 149.5 (C-6), 151.8 (C-20), 151.9 (C-
2), 163.3 (C-10), 166.2 (C-21); 119Sn NMR (112 MHz, CDCl3) d:
ꢀ580.6; MS(FAB+) [m/z] (%): [MÅ+, 627] (5); [(MꢀPh)+, 550] (5),
[(MꢀPyCOO)+, 505] (20), [(MꢀPyCOOꢀ2Ph)+, 351] (5); HR-MS
(FAB+) m/z: 549.9980 (Calcd. for the fragment ion C24H17O3N3ClSn),
Observed 549.9989. Anal. Calc. for C30H22N3O3ClSn: C, 57.50; H,
3.54; N, 6.71. Found: C, 56.30; H, 3.60; N, 6.32%.
5.9. Complex 1i
0.3030 g (1.049 mmol) diphenyltin oxide and 0.1290 g
(1.048 mmol) of 2-picolinic acid in 30 mL benzene was added to
a solution of 0.1 mL (1.048 mmol) of 2-pyridinecarboxaldehyde,
0.1144 g (1.048 mmol) of 2-aminophenol. The combined solution
was refluxed for 40 min. After evaporating 20 mL of solvent to vac-
uum, a precipitate formed which was then filtered to give 0.6175 g
(99.5%) of a dark red solid, m.p. 295 °C; IR (KBr cmꢀ1): 1657 (s,
m
asymCO2), 1343 (s, msymCO2), 1594 (s, mC@N), 421 (w, m
Sn–N); 1H
NMR (300 MHz, CDCl3) d: 6.67 (1H, ddd, J = 8.6, 7.0, 1.4 Hz, H-
13), 6.97–7.02 (6H, m, H-m, H-p), 7.28 (1H, dd, J = 9.1, 1.4 Hz, H-
11), 7.39–7.44 (2H, m, H-12, H-14), 7.51 (1H, d, J = 8.1 Hz, H-5),
7.56 (1H, ddd, J = 7.4, 5.5, 1.3 Hz, H-3), 7.60–7.63 (4H, m, H-o),
7.64 (1H, ddd, J = 7.6, 5.2, 1.2 Hz, H-17), 7.89 (2H, ddd, J = 7.8, 7.6,
1.5 Hz, H-4, H-18), 8.33 (1H, d, J = 7.8. Hz, H-19), 8.49 (1H, s, H-
7), 9.87 (1H, d, J = 5.2. Hz, H-16), 10.31 (1H, d, J = 5.5 Hz, H-2);
13C NMR (75 MHz, CDCl3), d: 115.9 (C-14), 116.5 (C-11), 121.1 (C-
13), 125.5 (C-19), 126.4 (C-17), 126.6 (C-3), 127.2 (C-5), 128.0 (C-
p), 128.1 (C-m), 133.6 (C-12), 134.3 (2J(13C–119Sn) = 66.9 Hz, C-o),
139.1 (C-4), 139.9 (C-18), 142.5 (C-7), 148.1 (C-16), 148.3 (C-6),
151.6 (C-2); 119Sn NMR (112 MHz, CDCl3) d: ꢀ583.8; MS (FAB+)
[m/z] (%): [MÅ+, 593] (5); [(MꢀPh)+, 516] (10), [(MꢀPyCOO)+, 471]
(40), [(MꢀPyCOOꢀPh)+, 394] (20), [(MꢀPyCOOꢀ2Ph)+, 317] (10);
HR-MS (FAB+) m/z: 516.0370; (Calcd. for the fragment ion
C24H18N3O3Sn), Observed 516.0372. Anal. Calc. for C30H23N3O3Sn:
C, 60.84; H, 3.91; N, 7.10. Found: C, 58.81; H, 4.34; N, 6.61%.
5.12. Complex 1l
Following the procedure described for 1i, complex 1l
was formed from 0.1 mL of pyridinecarboxaldehyde, 0.1614 g
(1.047 mmol) of 2-amino-4-nitrophenol, 0.3031 g (1.049 mmol)
of diphenyltin oxide and 0.1289 g (1.048 mmol) of 2-picolinic acid,
refluxed 20 min to give 0.6069 g (90.9% yield) of an orange solid,
m.p. 290 °C (dec); IR (KBr cmꢀ1): 1648 (s,
CO2), 1592 (s, C@N), 420 (w,
m
asymCO2), 1362 (s, msym-
m
m
Sn–N); 1H NMR (300 MHz, CDCl3) d:
6.95–7.09 (6H, m, H-m, H-p), 7.50 (4H, dd, J = 7.7, 1.8 Hz, H-o), 7.29
(1H, d, J = 9.5 Hz, H-11), 7.63 (1H, ddd, J = 7.5, 5.4, 1.4 Hz, H-3), 7.71
(1H, d, J = 7.4 Hz, H-5), 7.78 (1H, ddd, J = 7.7, 5.1, 1.2 Hz, H-17), 7.97
(1H, ddd, J = 7.5, 7.4, 1.65 Hz, H-4), 8.03 (1H, ddd, J = 7.7, 7.7,
1.7 Hz, H-18), 8.34 (1H, dd, J = 9.5, 2.8 Hz, H-12), 8.37 (1H, d,
J = 7.7. Hz, H-19), 8.48 (1H, d, J = 2.8 Hz, H-14), 8.72 (s, 1H, H-7),
9.79 (1H, d, J = 5.1 Hz, H-16), 10.32 (1H, d, J = 5.4 Hz, H-2); 13C
NMR (75 MHz, CD2Cl2), d: 114.1 (C-11), 120.9 (C-12), 125.8 (C-5),
127.3 (C-3), 128.1 (C-17), 128.6 (2J(13C–119Sn) 119.42 Hz, C-m),
128.7 (C-p), 128.7 (C-14), 128.9 (C-19), 130.2 (C-9), 134.0 (C-o),
137.0 (C-13), 140.2 (C-4), 140.8 (C-18), 147.1 (C-ipso), 147.4 (C-
7), 148.1 (C-16), 149.3 (C-6), 151.1 (C-20), 152.0 (C-2), 166.1 (C-
10), 170.0 (C-21); 119Sn NMR (112 MHz, CD2Cl2) d: ꢀ580.5; MS
5.10. Complex 1j
Following the procedure described for complex 1i, complex 1j
was formed from 0.1 mL (1.048 mmol) of 2-pyridinecarboxalde-
hyde, 0.1290 g (1.048 mmol) of 2-amino-4-methylphenol,
0.3031 g (1.049 mmol) diphenyltin oxide and 0.1289 g
(1.048 mmol) of 2-picolinic acid, thereby producing 0.6030 g
(94.9%) of a dark red solid, m.p. 250 °C (dec); IR (KBr cmꢀ1):
1657 (s, masym CO2), 1345 (s,
msymCO2), 1598 (s, mC@N), 420 (w,
m
Sn–N); 1H NMR (300 MHz, CDCl3) d: 2.30 (3H, s, Ar-CH3), 6.90–